Related Experiment Videos
[Nitrogen oxide inhalation in acute pulmonary failure]
T H Jensen1, S W Henneberg, L Heslet
1Intensiv Afdeling, Rigshospitalet, København.
Ugeskrift for Laeger
|May 15, 1995
Summary
Nitric oxide (NO) inhalation successfully treated two severe cases of adult respiratory distress syndrome (ARDS), improving oxygenation and reducing lung pressures. This approach offers a potential alternative to extracorporeal membrane oxygenation (ECMO) for ARDS patients.
Area of Science:
- Critical Care Medicine
- Pulmonology
- Medical Innovation
Background:
- Adult Respiratory Distress Syndrome (ARDS) presents significant challenges in critical care.
- Extracorporeal Membrane Oxygenation (ECMO) is an invasive option for severe ARDS.
- Identifying less invasive, effective treatments for ARDS is crucial.
Observation:
- Two adult patients with severe ARDS, one due to sepsis and another to trauma, met criteria for ECMO.
- Both patients were treated with inhaled nitric oxide (NO).
Findings:
- Inhaled NO administration led to substantial improvements in oxygenation.
- Pulmonary arterial pressure and peak inspiratory pressure were significantly reduced.
- Treatment with NO was well-tolerated, without reported side effects, and easily administered via ventilator.
Implications:
- Inhaled NO demonstrates potential as a safe and effective therapy for severe ARDS.
- This treatment may offer a viable alternative to ECMO, potentially reducing invasiveness and complications.
- Further investigation into inhaled NO for ARDS management is warranted before considering ECMO.